Podcast #313: Flu Screening

Author: Peter Bakes, M.D.

Educational Pearls:

  • High risk patients: underlying lung disease, immunocompromised, extremes of age (<2 or >65), underlying cardiac/renal/neurologic disease, and pregnant women.
  • Testing: RT-PCR (RNA based test that is both sensitive and specific)
  • Workup: comorbidities dictate whether or not they are screened; CXR indicated in high risk patients with respiratory symptoms.
  • Morbidity from flu comes from secondary pneumonia, sepsis, and septic shock.
  • Treatment options are Tamiflu and Relenza (Relenza is contraindicated in patients with lung disease).
  • High risk patients see average of 2.5 days shortening of illness and a decrease in illness severity. Low risk patients see average of 1.5 days shortening of illness.

References:

https://www.cdc.gov/flu/about/disease/high_risk.htm

Binnicker MJ, Espy MJ, Irish CL, Vetter EA. Direct Detection of Influenza A and B Viruses in Less Than 20 Minutes Using a Commercially Available Rapid PCR Assay. J Clin Microbiol. 2015 Jul; 53(7): 2353-4.

Longo, Dan L. (2012). “187: Influenza”. Harrison’s principles of internal medicine (18th ed.). New York: McGraw-Hill. ISBN 9780071748896.

Leave a Reply

Your email address will not be published. Required fields are marked *